75 related articles for article (PubMed ID: 7201918)
1. [Liposomes as the carriers of antitumor chemical preparations in neoplastic liver lesions].
Gruntenko EV; Nikolin VP; Matienko NA; Kaledin VI; Vakhrusheva TA
Dokl Akad Nauk SSSR; 1982; 265(1):225-8. PubMed ID: 7201918
[No Abstract] [Full Text] [Related]
2. [Suppression of tumor growth in the liver by cis-diamminedichloroplatinum as large oligolamellar liposomes prepared by freezing and thawing].
Kaledin VI; Nikolin VP; Popova NA; Budker VG; Semenova LA
Vopr Onkol; 1989; 35(5):599-602. PubMed ID: 2741430
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of cis-diamminodichloroplatinum incorporated into liposomes on lymphogenic metastases of transplanted mouse tumors].
Kaledin VI; Matienko NA; Budker VG; Nikolin VP; Gruntenko EV
Dokl Akad Nauk SSSR; 1978; 242(2):473-6. PubMed ID: 710256
[No Abstract] [Full Text] [Related]
4. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
[TBL] [Abstract][Full Text] [Related]
5. Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes.
Kaledin VI; Matienko NA; Nikolin VP; Gruntenko YV; Budker VG
J Natl Cancer Inst; 1981 May; 66(5):881-7. PubMed ID: 6939932
[TBL] [Abstract][Full Text] [Related]
6. Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo.
Lee CM; Tanaka T; Murai T; Kondo M; Kimura J; Su W; Kitagawa T; Ito T; Matsuda H; Miyasaka M
Cancer Res; 2002 Aug; 62(15):4282-8. PubMed ID: 12154030
[TBL] [Abstract][Full Text] [Related]
7. [Effect of hepatic arterial injection of liposome-encapsulated cisplatin upon hepatic carcinoma in rats].
Ono Y; Ohkusa A; Okafuji T; Yamamoto T; Kawakami A; Shindo H; Ishida O; Ogiso T; Kinoshita T; Yoshioka H
Gan To Kagaku Ryoho; 1993 May; 20(7):965-7. PubMed ID: 8489304
[No Abstract] [Full Text] [Related]
8. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
9. [New models of experimental chemotherapy of tumors].
Treshchalina EM; Andronova NV; Kobliakov VA; Raĭkhlin NT
Vopr Onkol; 2001; 47(6):701-5. PubMed ID: 11826492
[TBL] [Abstract][Full Text] [Related]
10. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.
Xie K; Huang S; Dong Z; Gutman M; Fidler IJ
Cancer Res; 1995 Jul; 55(14):3123-31. PubMed ID: 7541713
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of Ca-double-stranded RNA from sodium nucleinate].
Zakharian RA; Mespropian NP; Movsesian AV; Agabalian AS; Akopian ZhI
Eksp Onkol; 1985; 7(3):54-6. PubMed ID: 4017933
[TBL] [Abstract][Full Text] [Related]
12. [Carcinostatic action of synthetic polymers on transplantable tumors].
Korosteleva TA; Movsesian KA; Meiia NV; Nesterova VI; Sorokin AIa
Vopr Onkol; 1982; 28(6):39-41. PubMed ID: 7090295
[No Abstract] [Full Text] [Related]
13. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
[TBL] [Abstract][Full Text] [Related]
14. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of long-circulating nolatrexed dihydrochloride liposomes and its antitumor activity].
Chen SZ; Wang SM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):403-5. PubMed ID: 18359701
[TBL] [Abstract][Full Text] [Related]
16. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma].
Satoh H
Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361
[TBL] [Abstract][Full Text] [Related]
17. Target therapy of ovarian carcinoma by monoclonal antibodies bearing chemical drugs entrapped in liposomes.
Qian HN; Li WJ
Chin Med J (Engl); 1993 May; 106(5):343-7. PubMed ID: 8404276
[TBL] [Abstract][Full Text] [Related]
18. [31P-NMR study of the dynamics of energy metabolism in hepatoma 22-a cells exposed to antitumor preparations].
Dubinskiĭ VZ; Semenova NA; Sibel'dina LA
Dokl Akad Nauk SSSR; 1985; 281(1):180-3. PubMed ID: 3996197
[No Abstract] [Full Text] [Related]
19. [Prophylaxis of regional lymph node metastasis with liposomes].
Popova NA; Nikolin VP; Kaledin VI
Biull Eksp Biol Med; 1999 Apr; 127(4):450-1. PubMed ID: 10367134
[No Abstract] [Full Text] [Related]
20. Antitumor effect of polysaccharide coated liposomal adriamycin on AH66 hepatoma in nude mice.
Ichinose K; Yamamoto M; Khoji T; Ishii N; Sunamoto J; Kanematsu T
Anticancer Res; 1998; 18(1A):401-4. PubMed ID: 9568109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
